INS and type 1 diabetes mellitus: In order to test the tolerogenic ability of the liver, Akbarpour et al. treated T1D in mice by injecting an integrase-competent lentiviral vector (ICLV) that targeted the expression of the transgene immunodominant epitope of insulin (InsB9–23) in hepatocytes.